Table 4. Parameters of the model with covariates for age-group 50–59.
| Healthy to preclinical | Healthy to death | Preclinical to clinical | Preclinical to death | |
|---|---|---|---|---|
| Transition rate (95% CI) |
0.00267 (0.00228, 0.00313) |
0.00230 (0.00205, 0.00259) |
0.32940 (0.22970, 0.47250) |
0.00230 (0.00205, 0.00259) |
|
Log-linear effect of covariate on transition rate (90% CI) | ||||
| Age at entry | 0 | 0.10210 (0.06843, 0.13570) | 0 | 0.10210 (0.06843, 0.13570) |
| Absence of history of breast disease | −0.3787 (−0.6331, −0.1243) | 0 | 0 | 0 |
| Menstruation length (years) | 0.02821 (0.01466, 0.04176) | −0.01641 (−0.02888, −0.003948) | 0 | −0.01641 (−0.02888, −0.003948) |
| Number of live birthsa |
−0.5654 (−0.8124, −0.3185) |
−0.3095 (−0.549, −0.07008) |
0 |
−0.3095 (−0.549, −0.07008) |
| Mean sojourn time (95% CI) |
3.035 (2.116, 4.354) |
|
|
|
| Sensitivity (95% CI) | 0.712 (0.536, 0.841) | |||
Abbreviation: CI=confidence interval.
a
The baseline is a woman with no live birth.